The global oral thrush market is expected grow at a CAGR of 4.4% and attain USD 9.5 Bn by the end of the forecast period of 2017-2023, as per a research report published by Market Research Future (MRFR).

The market has observed continued growth on account of rising prevalence of oral thrush across the globe. Oral thrush is caused by an organism called Candida albicans which occurs naturally in about half of the world's population as a normal oral microbiota, and the disease is developed when Candida albicans is in excess and thus is a very common disease. The rise in chemotherapy and radiotherapy has supported the market growth. Oral thrush becomes quite regular after chemotherapy and radiation and is also common in people who take steroids. Rising prevalence of diabetes also fosters the growth of the market as oral thrush is also common among diabetic patients.

Get Free Sample Copy @ https://www.marketresearchfuture.com/sample_request/4417

Oral thrush is common among women and old people, and a rise in geriatric population boosts the market growth. Smoking too causes oral thrush and rise in smoking population also drives the growth of the market. Neglected hygiene and malnutrition (iron, vitamin B12, folic acid deficiency), especially among under-developed regions of the world is a crucial reason for the rising incidence of oral thrush. Availability of anti-fungal drugs and products and high acceptance of anti-fungal drugs among patients is also propelling the growth of the market. A significant rise in initiatives towards the education of oral health care and inducing awareness about the available treatment options provide impetus to market growth. Factors such as lack of awareness, loss of patent and growth of generics are expected to hinder the growth of the market over the forecast period.

The Global Oral Thrush Market is increasing owing to the rising prevalence of oral candidiasis and the demand for effective medical care to treat the thrush. Lifestyle has a significant influence on the physical and mental health of human being. Undoubtedly, today’s unhealthy, inactive or sedentary lifestyle is the main driving force behind the prevalence of Candida, further substantiating the market growth.

Key Players in the Global Oral Thrush Market

Some of key players profiled in the report are Bayer AG, Teva Pharmaceuticals, Stellar Pharma, Pfizer Inc., Wockhardt Ltd., Ranbaxy Laboratories Limited, Bristol Laboratories, Glenmark Pharmaceuticals, GlaxoSmithKline Plc., and others.

Segmentation:

The global oral thrush market has been segmented on the basis of type, diagnosis, treatment, and end user.

Based on type, the market has been segmented as pseudomembranous, erythematous, hyperplastic, and others.

Based on diagnosis, the market has been segmented as examination, biopsy, endoscopy, and others.

Based on treatment, the market has been segmented as anti-fungal, immune-modulators, and others.

Based on the end user, the market has been segmented as hospitals & clinics, academic and research, and others.

Browse Complete 85 Pages Premium Research Report Enabled with Respective Tables and Figures @ https://www.marketresearchfuture.com/reports/oral-thrush-market-4417


About US:

Market Research Future (MRFR), enable customers to unravel the complexity of various industries through Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

Contact Us:

Market Research Future

Office No. 528, Amanora Chambers

Magarpatta Road, Hadapsar,

Pune - 411028

Maharashtra, India

Phone: +1 646 845 9312

Email: [email protected]